| http://www.w3.org/ns/prov#value | - Chair of EuropaBio???s SME platform, Tom Saylor believes that ???The Framework Programme is an important means of funding for research for biotechnology enterprises and should remain a central part of CSF. Increasing harmonisation and simplification of the rules is urgently needed to make the programme more attractive to applicants, particularly SMEs who often struggle with the burden of applicati
|
